Ammonium Sulfate Market Is Projected To Reach $3.44 Billion By 2022

Global Ammonium Sulfate Market is expected to reach USD 3.44 billion by 2022, according to a new report by Grand View Research, Inc. Growing fertilizers demand on account of growing population and decreasing arable land is expected to remain a key driving factor for global ammonium sulfate market. Shift in trend towards increasing crop yield by increasing nutrient contents such as nitrogen and sulfur in soil is also expected to have a positive influence on the market growth. Presence of stringent regulatory norms particularly in developed markets of Germany, 

France, UK and the U.S. are expected to remain a key challenge for market participants.

Solid ammonium sulfate emerged as the leading product segment and accounted for over three quarters of total demand in 2014. Solid ammonium sulfate is also expected to witness highest growth of 2.45% from 2015 to 2022. Granular ammonium sulfate finds its application across a wide range of end-use industries which has contributed towards its growth.

Full Research Report on Global Ammonium Sulfate Market Analysis:
http://www.grandviewresearch.com/industry-analysis/ammonium-sulfate-market

Further key findings from the report suggest:

• Global ammonium sulfate market demand 24.60 million tons in 2014 and is expected to reach 29.81 million tons by 2022, growing at a CAGR of 2.43% from 2015 to 2022.
• Fertilizer emerged as the leading application segment and accounted for over 90% of total market volume in 2014. Continuous increase in population coupled with need to increase cultivation yield is expected to benefit the demand for ammonium sulfate in fertilizers. Novel applications such as food additives are expected to witness the highest growth of 2.90% from 2015 to 2022.
• Asia Pacific was the leading regional market with demand share estimated at 39.0% in 2014. Presence of a large agriculture industry in China, India and South East Asian countries is expected to remain a key driving factor for the regional market. The region is also expected to witness the highest growth of 2.57% from 2015 to 2022.
• Central and South America is expected to witness significant growth to account over 17% of the global market by 2022. Ammonium sulfate demand in Brazil is expected to rise over the forecast period and have positive impact on the overall regional market.
• Ammonium sulfate industry is fragmented with presence of large number significant market players across the globe. Some leading companies operating in the global market include DSM, Honeywell and BASF. Other companies include Sumitomo Chemicals, Helm AG, Evonik Industries, Domo Chemicals, AkzoNobel, Lanxess, Rentech and Agrium.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/agrochemicals-and-fertilizers

Grand View Research has segmented the Global Ammonium Sulfate Market on the basis of product, application and region:

Global Ammonium Sulfate Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Solid
• Liquid

Global Ammonium Sulfate Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022)

• Fertilizers
• Food Additives
• Industrial Use
• Others

Global Ammonium Sulfate Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2012 - 2022

• North America
• U.S
• Canada
• Europe
• Germany
• France
• UK
• Spain
• Italy
• Asia Pacific
• India
• China
• Japan
• South Korea
• Central & South America
• Brazil
• Middle East and Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-ammonium-sulfate-market                       

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Regulatory Affairs Outsourcing Market Is Anticipated To Reach $12.4 Billion By 2025

Global Regulatory Affairs Outsourcing Market is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Outsourcing of regulatory affairs functions to CROs or other individual service providers offers life science companies the benefit to achieve cost efficiency and reduce the overall approval process time by eliminating delays associated with regulatory submission requirements. These benefits are primarily driving the outsourcing trend and hence impacting the market over the forecast period.

The augmenting disease prevalence in Asia Pacific and MEA regions and increasing number of clinical trials being conducted is stimulating life science companies to expand into these regions thereby increasing the demand of these services. Changing regulatory landscape especially in developing regions and stringent directive requirements in developed regions such as North America and Europe are driving the adoption of outsourcing trend in regulatory affairs function. Growth in emerging areas such as biosimilars and orphan drug is expected to stimulate the demand for regulatory expertise thereby contributing to the growth of regulatory affairs outsourcing market.

Full Research Report on Global Regulatory Affairs Outsourcing Market Analysis:
http://www.grandviewresearch.com/industry-analysis/regulatory-affairs-outsourcing-market

Further Key Findings From The Study Suggest:

• Based on product, legal representation is expected to witness lucrative growth during the forecast period owing to healthcare reforms especially in emerging regions such as India and China. Also, rising demand of legal representation in regions such as Europe for gaining market authorization for companies who do not have an established base in the region. For instance, small or mid-size biopharmaceutical companies having domestic only, requires legal representative if they want to expand their presence in European countries such as UK and Germany. Regulatory writing and publishing is expected to be the leading segment during the forecast period.
• Few of the industry players for the regulatory affairs outsourcing market are Clinical Research, Clinilabs Inc., Criterium Inc., PRA International, Promedica International, Wuxi AppTec, Medpace Inc.The other major players include Pharmaceutical Product Development(PPD), PAREXEL International Corporation, Charles River Laboratories International Inc., and Covance Inc.
• There has been a trend of strategic partnership between services providers for increasing service portfolio or expanding regional presence. For instance, PPD formed a joint venture with Shin Nippon Biomedical Laboratories Ltd. (SNBL), leading provider of development services to biopharmaceuticals, to provide clinical development services in Japan including function based services such as regulatory and pharmacovigilance.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Regulatory Affairs Outsourcing Market on the basis of service, and region:

Regulatory Affairs Outsourcing Product Outlook (Revenue, USD Million; 2014 - 2025)

• Regulatory consulting
• Legal Representation
• Regulatory writing and publishing
• Product registration and clinical trial applications
• Others

Regulatory Affairs Outsourcing Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Mexico
• Brazil
• MEA
• South Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-regulatory-affairs-outsourcing-market                      

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Thermoplastic Polyester Elastomer (TPEE) Market Is Projected To Reach $1.49 Billion By 2025

Global Thermoplastic Polyester Elastomer (TPEE) Market is expected to reach USD 1.49 billion by 2025, according to a new report by Grand View Research, Inc. Progress in plastics technologies & compounding or processing capabilities are expected to complement industry growth over the forecast period. 

Thermoplastics polyester resins combine excellent electrical, mechanical, and thermal properties with high dimensional stability & chemical resistance among other advantageous characteristics. Growing penetration of bio-based feedstock from renewable resources such as biomass has had a significant impact on sustainable consumption patterns in the market.

Significant growth in end-use industries such as automotive, construction, industrial manufacturing, electrical & electronics, consumer goods and others in emerging economies is a major factor driving TPEE demand. The value chain consists of raw material manufacturers producing ethylene, methacrylic acid and SBS rubber, which are highly dependent upon crude oil supply and challenge suppliers.

Increasing R&D activities by numerous companies involved in the production, distribution and recycling of TPEE compounds are expected to drive investments in the market and boost growth. New entrants are likely to be compelled to innovate in order to compete with existing multinational companies and gain a foothold in the market.

Automotive emerged as the dominant end-use market with over 42% of the volume share in 2016. TPEE materials that foster higher performance of components such as airbag accessories, lock assemblies, door handle seals, silencer gears and others are anticipated to drive industry growth over the forecast period.

Full Research Report on Global Thermoplastic Polyester Elastomer Market (TPEE) Market Analysis: 
http://www.grandviewresearch.com/industry-analysis/thermoplastic-polyester-elastomer-tpee-market

Further key findings from the report suggest:

• The global thermoplastic polyester elastomer market exceeded 230 kilo tons in 2016 and is expected to grow at a CAGR of 4.9% from 2016 to 2025
• Increasing consumer interest in miniaturized and ‘smart’ wearable electronics has driven TPEE consumption in this segment. The electrical & electronics end-use market is likely to account for about USD 290 million by 2025, growing at CAGR of 6.2% from 2017 to 2025.
• Rising expenditure on healthcare and medical facilities is another driving factor with expanding geriatric population across developed economies and numerous epidemic breakouts in recent years. The compound is widely used in the production of medical devices, equipment and even surgical instruments owing to its high safety features & sustainability.
• The U.S. is anticipated to remain a major market in the industry on account of the high levels of industrialization and concentrated large players present in the country
• China is also anticipated to remain a dominant player with increasing investments in the region’s industries such as automotive, construction, medical and electronics. Rising disposable income is also expected to play a key role in developed TPEE production capabilities as consumers invest higher levels in advanced goods.
• The industry is fragmented in nature with large multinationals occupying dominant position in the market such as DuPont, A. Schulman, BASF, Ashland, Covestro, SABIC, Mitsubishi Chemicals and others. Smaller to medium sized players occupy a relatively minor share with limited product portfolios and presence.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/plastics-polymers-and-resins

Grand View Research has segmented the Global Thermoplastic Polyester Elastomer Market (TPEE) Market on the basis of end-use, and region:

Thermoplastic Polyester Elastomer End-use Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• Automotive
• Electrical & Electronics
• Industrial
• Medical Devices
• Consumer Goods
• Others

Thermoplastic Polyester Elastomer Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Italy
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa
• Saudi Arabia

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-thermoplastic-polyester-elastomer-tpee-market                     

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Melanoma Therapeutics Market Size Is Expected To Reach $12.4 Billion By 2025

Global Melanoma Therapeutics Market is expected to reach USD 12.4 billion by 2025, according to a new report by Grand View Research, Inc. Increasing incidence of chronic diseases such as melanoma, skin cancer, and skin allergies is an important driver of the market.

According to CDC, over 71,943 people were affected by melanoma in 2013. The American Cancer Society estimates that this number will go up to 87,100 in 2017, thus highlighting the need for melanoma drugs over the forecast period.

Increasing number of FDA approvals and introduction of novel therapeutics with enhanced efficacy are also anticipated to present growth opportunities. Within a period of 6 years, i.e., from 2011 to 2016, around eight biologics have been approved for the treatment of this disease, which include Opdivo, Yervoy, Cotellic, Zelboraf, Keytruda, Mekinist, Tafinlar, and Imlygic.

Companies are undertaking various R&D activities to find new indications for existing products and development of innovative molecules. For instance, in September 2014, the U.S. FDA approved patented drug Keytruda (Merck & Co., Inc.) to treat metastatic melanoma, thereby extending the therapeutic application of its product. This drug was initially approved for treatment of non-small cell lung cancer.

Furthermore, many pharmaceutical companies in the U.S., Europe, and Asia Pacific are focusing on development of new biologics. For instance, in March 2017, Daiichi Sankyo Company, Limited announced a collaborative drug discovery project—Take a New challenge for Drug discovery (TaNeDS)—to facilitate new drug development through collaborations. Moreover, it entered into a strategic research collaboration with AgonOX, Inc. to develop new immunotherapy drugs for the immuno-oncology segment. Approval of novel products over the forecast period is anticipated to boost market growth.

Full Research Report on Global Melanoma Therapeutics Market Analysis:
http://www.grandviewresearch.com/industry-analysis/melanoma-therapeutics-market

Further Key Findings From the Study Suggest: 

• Targeted therapy segment is expected to show lucrative growth owing to benefits such as low adverse effects and higher efficiency
• Branded drugs held a dominant share of the industry because of patent exclusivity
• Biologics, such as Opdivo and Cotellic, are expected to exhibit lucrative growth over the forecast period owing to increase adoption and advantages such improved therapeutic effects
• The patent for Yervoy will expire in 2022 in the U.S. and in 2020 in Europe. This is expected to provide growth opportunities for new market entrants
• Asia Pacific is expected to exhibit lucrative CAGR over the forecast period
• Key market players are increasing R&D efforts for discovery and development of novel drugs for the treatment of melanoma

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/pharmaceuticals

Grand View Research has segmented the Global Melanoma Therapeutics Market on the basis of therapy, drugs, and region:

Melanoma Therapeutics Therapy Outlook (Revenue, USD Million, 2014 - 2025)

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Radiation Therapy

Melanoma Therapeutics Drugs Outlook (Revenue, USD Million, 2014 - 2025)

• Opdivo
• Yervoy
• Mekinist+Tafinlar
• Keytruda
• Cotellic
• Zelboraf
• Imlygic
• Generics

Melanoma Therapeutics Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-melanoma-therapeutics-market                    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Intravascular Warming Systems Market Is Projected To Grow At A CAGR Of 8.4% Over The Forecast Period 2014-2025

Global Intravascular Warming Systems Market is expected to reach a value of USD 565.4 million by 2025, according to a new report by Grand View Research, Inc. Increasing number of surgical procedures is the most significant factor projected to boost the growth of the market during the forecast period. According to the WHO, around 266.2 to 359.5 million surgeries were performed globally in 2012 and this number is expected to increase in the near future. This in turn results in the need for intravascular warming products pre-, intra-, and postoperatively.

Rising adoption of technologically advanced medical devices by operating rooms, ICUs, and emergency rooms is another major factor contributing to the growth of the market. The manufacturers are focusing on developing better in-line intravascular warming systems, which facilitate rapid flow of normothermic blood and intravenous fluids. The portability feature of these product also facilitates convenient usage during trauma or while transporting a patient to the hospital. Thus, the popularity of these devices is growing at a rapid pace, which is expected to propel the growth of the market.

Full Research Report On Global Intravascular Warming Systems Market Analysis:
http://www.grandviewresearch.com/industry-analysis/intravascular-warming-systems-market

Further key findings from the study suggest:

• Perioperative care was the largest revenue-generating segment in 2015 in the intravascular warming systems market. This is due to rising adoption of technologically advanced medical devices in operating rooms and ICUs
• The acute care segment is expected to grow at highest rate during forecast period, owing to increasing adoption of intravascular warming systems for the treatment of accident and trauma patients
• In 2015, operating rooms segment held the largest revenue share in this market, owing to the increasing number of surgical procedures worldwide
• The emergency rooms segment is expected to grow at high pace during the study period, due to escalating number of patients requiring emergency medical care
• North America held the largest share in the year 2015. The factors that can be attributed to such growth include well-developed healthcare infrastructure and high incidence of hypothermia & related death rates in countries like the U.S.
• Asia Pacific is expected to grow at a lucrative CAGR owing to rising number of surgical procedures due to large number of road accident cases in India and China.
• Some of the key players include Stryker Corp.; 3M; The 37 Company; Smiths Medical, Inc.; Geratherm Medical AG; Inditherm Plc.; Becton, Dickinson and Company; and Estill Medical Technologies, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare

Grand View Research has segmented the Global Intravascular Warming Systems Market on the basis of application, end use, and region:

Intravascular Warming Systems Application Outlook (Revenue, USD Million; 2014-2025)

• Acute care
• Perioperative care

Intravascular Warming Systems End-use Outlook (Revenue, USD Million; 2014-2025)

• Operating rooms
• ICUs
• Emergency rooms
• Others

Intravascular Warming Systems Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-intravascular-warming-systems-market                     

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Structural Heart Imaging Market Size Is Expected To Reach $25.3 Billion By 2025

Global Structural Heart Imaging Market is expected to reach USD 25.3 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in incidence of Structural Heart Diseases (SHDs), growing awareness about diseases, and technological advancements in imaging modalities are anticipated to drive the market during the forecast period.

Furthermore, clearer high-quality images are necessary for management of patients suffering from SHDs. Hence, availability of technologically advanced devices and increase in their adoption are likely to boost the market in the coming years. Echocardiogram, Magnetic Resonance Imaging (MRI) and CT are the most widely used modalities for SHI.

Echocardiogram accounted for the maximum share in the SHI market in 2016 and is estimated to maintain its dominance during the forecast period. This can be attributed to the adoption of echo test as a first-line imaging technique, low cost as compared to CT & MRI, and its superiority in visualization of intracardiac structures.

MRI segment is expected to witness the fastest growth in the coming years due to technological advancements, as well as the ability of MRI to provide accurate & reproducible quantification of ventricular function and image the entire body.

Full Research Report on Global Structural Heart Imaging Market Analysis:
http://www.grandviewresearch.com/industry-analysis/structural-heart-imaging-shi-market

Further Key Findings From the Report Suggest:

• Globally, the SHI market is expected to exhibit a CAGR of almost 10% from 2017 to 2025, which can be attributed to increase in investment by players for advancements in imaging of structural heart diseases, as well as increase in number of patients suffering from SHD.
• By modality, echocardiogram segment dominated the market in 2016 and is estimated to account for more than 50.0% of market share by 2025. This can be attributed to its superiority in visualization of intracardiac structures
• MRI segment is likely to drive the market at the fastest rate in the coming years due to technological advancements in MRI devices. Furthermore, this modality does not use ionizing radiation, making it more suitable than CT for diagnosis of children & pregnant women
• Geographically, in 2016,North America accounted the largest share and is expected to maintain its dominance during forecast period due to availability of technologically advanced devices, high healthcare expenditure, and favorable reimbursement policies for imaging
• Asia Pacific is likely to witness lucrative growth in the coming years owing to growing investments by players in the region and increase in well-equipped & sophisticated hospitals. These factors are expected to result in rise in demand for advanced procedures for structural heart diseases
• Some of the key players operating in the SHI market are Toshiba Corporation; Siemens Healthineers; Koninklijke Philips N.V.; Shimadzu Corporation; Pie Medical Imaging; Circle Cardiovascular Imaging, Inc.; TomTec Imaging Systems GmbH; CardioComm Solutions, Inc.; and HeartSciences.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the Global Structural Heart Imaging Market on the basis of imaging modality and region:

Imaging Modality Outlook (Revenue, USD Million, 2014 - 2025)

• Echocardiogram
• Angiogram
• CT
• MRI

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• Japan
• China
• Central & South America
• Brazil
• Mexico
• Middle East & Africa
• South Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-structural-heart-imaging-shi-market                    

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com

Dairy Processing Equipment Market Demand Was Valued At USD 8.84 Billion In 2016 And Anticipated To Reach USD 14.84 Billion By 2025

Global Dairy Processing Equipment Market is anticipated to reach USD 14.84 billion by 2025, according to a new report by Grand View Research, Inc.Favorable regulatory scenario and removal of milk quota in the European Union, are anticipated to favor industry growth.

The industry is expected to grow at a robust pace over the forecast period. A broad range of diverse products and rising importance of automation process in dairy products is expected to surge the demand for processing equipment. Milk processing companies are trying to reduce the production cost for processing milk and other dairy products to gain profitability.

The players present in the industry are trying to develop new and improved technologies to gain a competitive edge on other players. Major players are shifting towards process automation for reducing direct labor cost, improving quality, increasing productivity, maintaining consistently, and eliminating contamination source. Market players are also developing new and improved technology such as rumination sensors & cow activity system, robotic milking systems technology, and regular calf feeder technologies to enhance the productivity in dairy industry.

The global demand for homogenizers type in the industry is growing rapidly owing to various advantages of the products. Helping in reducing the bacterial & others microbiological activity, increasing the shelf life, and improving properties such as color, flavor, consistency, taste & texture of a product are some of its advantages. These factors are expected to support the growth of the homogenizers market over the forecast period. 

Full Research Report on Global Dairy Processing Equipment Market Analysis:
http://www.grandviewresearch.com/industry-analysis/dairy-processing-equipment-market

Further key findings from the report suggest:

• The global demand for dairy processing equipment market was valued at USD 8.84 billion in 2016. The market is anticipated to reach USD 14.84 billion by 2025, while growing at a CAGR of 6.0% from 2017 to 2025.
• Pasteurizers segment dominated the market in 2016 followed by homogenizers segment
• Cheese is the largest application segment in 2016 and is projected to follow the same growth trend over the forecast period. The segment is expected to grow at a CAGR of 6.0% over the forecasted period.
• Asia Pacific region is anticipated to have the fastest growth. The region is projected to grow at a CAGR of 6.4% over the forecast period.
• Some of the major players in the industry include SSP Pvt Limited, Inoxpa SA, GEA Group, Alfa Laval Corporate AB, IDMC Limited, A&B Process Systems, Feldmeier Equipment, Inc., Sealtech Engineers, Gemak Ltd., and Van den Heuvel Dairy & Food Equipment B.V.

View more reports of this category by Grand View Research at:
http://www.grandviewresearch.com/industry/food-safety-and-processing

Grand View Research has segmented the Global Dairy Processing Equipment Market by equipment type, application, and region:

Equipment Type Outlook (Revenue, USD Million, 2014 - 2025)

• Homogenizers
• Membrane filtration equipment
• Separators
• Mixing & blending equipment
• Evaporators & dryer equipment
• Pasteurizers
• Others

Application Outlook (Revenue, USD Million, 2014 - 2025)

• Cheese
• Processed Milk
• Yogurt
• Protein Ingredients
• Milk Powder
• Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• France
• Netherland
• Germany
• Asia Pacific
• Australia
• New Zeeland
• India
• Central & South America
• Brazil
• Argentina
• Middle East & Africa

View Press Release Of This Report by Grand View Research: http://www.grandviewresearch.com/press-release/global-dairy-processing-equipment-market                   

About Grand View ResearchGrand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit: www.grandviewresearch.com